Exitstrategien aus der Immuntherapie - Ausstieg ist oft riskant
Author:
Publisher
Springer Science and Business Media LLC
Link
http://link.springer.com/content/pdf/10.1007/s15036-020-0265-5.pdf
Reference20 articles.
1. Klag T, Wehkamp J, Stange EF. Wirkmechanismen und Wirkung von Biologika und JAK-Inhibitoren bei CED. GASTRO-NEWS 2019;06(1):26-34
2. Torres J, Boyapati RK, Kennedy NA, Louis E, Colombel JF, Satsangi J. Systematic Review of Effects of Withdrawal of Immunomodulators or Biologic Agents From Patients With Inflammatory Bowel Disease. Gastroenterology 2015;149(7):1716-30
3. Casanova MJ, Chaparro M, García-Sánchez V et al. Evolution After Anti-TNF Discontinuation in Patients With Inflammatory Bowel Disease: A Multicenter Long-Term Follow-Up Study. Am J Gastroenterol 2017;112(1):120-31
4. Martin A, Nachury M, Peyrin-Biroulet L et al. Maintenance of remission among patients with inflammatory bowel disease after vedolizumab discontinuation: a multicentre cohort study. J Crohns Colitis. 2020 Jan 13. pii: jjaa005. doi: 10.1093/ecco-jcc/jjaa005. [Epub ahead of print]
5. Van Assche G, Magdelaine-Beuzelin C, D'Haens G, Baert F et al. Withdrawal of immunosuppression in Crohn's disease treated with scheduled infliximab maintenance: a randomized trial. Gastroenterology 2008;134(7):1861-8
Cited by 2 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. Therapie-Update Morbus Crohn 2021;Gastro-News;2021-10
2. CED in Zeiten von COVID-19;Gastro-News;2020-06
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3